The research project getLIGHT (Novel light-inducible genome editing technology for crops) aimed to develop nothing less than a completely new genome editing method. In plant breeding, for example, this would enable the rapid and precise development of improved varieties without incurring expensive licensing fees for established methods such as CRISPR-Cas.
Brain Biotech acquires Breatec and Comix
On February 1, 2022, the German Brain Biotech AG announced the acquisition of Breatec B.V. including the Comix activities. The Dutch distributor, formulator and blender of functional food ingredients is primarily intended to expand the Brain Group's enzyme portfolio and open up new market fields.